File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: MicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy

TitleMicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy
Authors
Issue Date2015
PublisherMDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/cancers/
Citation
Cancers, 2015, v. 7 n. 3, p. 1643-1657 How to Cite?
AbstractIn recent decades Chinese medicine has been used worldwide as a complementary and alternative medicine to treat cancer. Plenty of studies have shown that microRNAs (miRNAs) play fundamental roles in many pathological processes, including cancer, while the anti-cancer mechanisms of Chinese medicinal herbs targeting miRNAs also have been extensively explored. Our previous studies and those of others on Chinese medicinal herbs and miRNAs in various cancer models have provided a possibility of new cancer therapies, for example, up-regulating the expression of miR-23a may activate the positive regulatory network of p53 and miR-23a involved in the mechanism underlying the anti-tumor effect of berberine in hepatocellular carcinoma (HCC). In this review, we survey the role of Chinese medicinal herbal products in regulating miRNAs in cancer and the use of mediating miRNAs for cancer treatment. In addition, the controversial roles of herb-derived exogenous miRNAs in cancer treatment are also discussed. It is expected that targeting miRNAs would provide a novel therapeutic approach in cancer therapy by improving overall response and survival outcomes in cancer treatment, especially when combined with conventional therapeutics and Chinese medicinal herbal products. © 2015 by the authors; licensee MDPI, Basel, Switzerland.
Persistent Identifierhttp://hdl.handle.net/10722/216732
ISSN
2015 SCImago Journal Rankings: 1.630
PubMed Central ID

 

DC FieldValueLanguage
dc.contributor.authorHONG, M-
dc.contributor.authorWang, N-
dc.contributor.authorTAN, HY-
dc.contributor.authorTsao, GSW-
dc.contributor.authorFeng, Y-
dc.date.accessioned2015-09-18T05:37:00Z-
dc.date.available2015-09-18T05:37:00Z-
dc.date.issued2015-
dc.identifier.citationCancers, 2015, v. 7 n. 3, p. 1643-1657-
dc.identifier.issn2072-6694-
dc.identifier.urihttp://hdl.handle.net/10722/216732-
dc.description.abstractIn recent decades Chinese medicine has been used worldwide as a complementary and alternative medicine to treat cancer. Plenty of studies have shown that microRNAs (miRNAs) play fundamental roles in many pathological processes, including cancer, while the anti-cancer mechanisms of Chinese medicinal herbs targeting miRNAs also have been extensively explored. Our previous studies and those of others on Chinese medicinal herbs and miRNAs in various cancer models have provided a possibility of new cancer therapies, for example, up-regulating the expression of miR-23a may activate the positive regulatory network of p53 and miR-23a involved in the mechanism underlying the anti-tumor effect of berberine in hepatocellular carcinoma (HCC). In this review, we survey the role of Chinese medicinal herbal products in regulating miRNAs in cancer and the use of mediating miRNAs for cancer treatment. In addition, the controversial roles of herb-derived exogenous miRNAs in cancer treatment are also discussed. It is expected that targeting miRNAs would provide a novel therapeutic approach in cancer therapy by improving overall response and survival outcomes in cancer treatment, especially when combined with conventional therapeutics and Chinese medicinal herbal products. © 2015 by the authors; licensee MDPI, Basel, Switzerland.-
dc.languageeng-
dc.publisherMDPI AG. The Journal's web site is located at http://www.mdpi.com/journal/cancers/-
dc.relation.ispartofCancers-
dc.rightsCreative Commons: Attribution 3.0 Hong Kong License-
dc.titleMicroRNAs and Chinese Medicinal Herbs: New Possibilities in Cancer Therapy-
dc.typeArticle-
dc.identifier.emailWang, N: ckwang@hku.hk-
dc.identifier.emailTsao, GSW: gswtsao@hku.hk-
dc.identifier.emailFeng, Y: yfeng@hku.hk-
dc.identifier.authorityWang, N=rp02075-
dc.identifier.authorityTsao, GSW=rp00399-
dc.identifier.authorityFeng, Y=rp00466-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.3390/cancers7030855-
dc.identifier.pmid26305257-
dc.identifier.pmcidPMC4586788-
dc.identifier.scopuseid_2-s2.0-84940975280-
dc.identifier.hkuros254681-
dc.identifier.volume7-
dc.identifier.issue3-
dc.identifier.spage1643-
dc.identifier.epage1657-
dc.publisher.placeSwitzerland-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats